Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Cleveland Clinic Explores Issues Associated with Integrating Genomics into Healthcare
March 30, 2011
A Cleveland Clinic official recently discussed three investigations that have added to the body of knowledge about how genomic medicine should be adopted into the existing healthcare infrastructure.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- Duke University Keeping an Eye on DTC Genomics Firms that Might be Infringing its APOE Patents
April 27, 2011 / Pharmacogenomics Reporter - Adding Alzheimer's Risk Option, 23andMe Revives Questions on Utility of DTC Genomics
April 20, 2011 / Pharmacogenomics Reporter - 2010 in Review: Genomic Medicine Experiences Growing Pains of Regulation, Economics, and Litigation
January 12, 2011 / Pharmacogenomics Reporter - CDC Advises Docs to Inform Patients of Limitations of DTC Gene Scans
August 11, 2010 / Pharmacogenomics Reporter - In Wake of 'Flawed' GAO Report, Consumer Genomics Firms Call for Regulatory Plan for DTC Industry
July 28, 2010 / Pharmacogenomics Reporter